cequa Drug Patent Profile
✉ Email this page to a colleague
When do Cequa patents expire, and when can generic versions of Cequa launch?
Cequa is a drug marketed by Sun Pharm and is included in one NDA. There are four patents protecting this drug.
This drug has thirty-six patent family members in twenty-four countries.
The generic ingredient in CEQUA is cyclosporine. There are eighteen drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the cyclosporine profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Cequa
A generic version of cequa was approved as cyclosporine by HIKMA on October 29th, 1999.
Summary for cequa
International Patents: | 36 |
US Patents: | 4 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 89 |
Patent Applications: | 4,337 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for cequa |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for cequa |
What excipients (inactive ingredients) are in cequa? | cequa excipients list |
DailyMed Link: | cequa at DailyMed |
Pharmacology for cequa
Drug Class | Calcineurin Inhibitor Immunosuppressant |
Mechanism of Action | Calcineurin Inhibitors Cytochrome P450 3A4 Inhibitors P-Glycoprotein Inhibitors |
US Patents and Regulatory Information for cequa
cequa is protected by four US patents.
Patents protecting cequa
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Topical cyclosporine-containing formulations and uses thereof
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Topical aqueous nanomicellar, ophthalmic solutions and uses thereof
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: INCREASE TEAR PRODUCTION IN PATIENTS WITH KERATOCONJUNCTIVITIS SICCA (DRY EYE).
Topical formulations and uses thereof
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: INCREASE TEAR PRODUCTION IN PATIENTS WITH KERATOCONJUNCTIVITIS SICCA (DRY EYE).
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sun Pharm | CEQUA | cyclosporine | SOLUTION;OPHTHALMIC | 210913-001 | Aug 14, 2018 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
Sun Pharm | CEQUA | cyclosporine | SOLUTION;OPHTHALMIC | 210913-001 | Aug 14, 2018 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
Sun Pharm | CEQUA | cyclosporine | SOLUTION;OPHTHALMIC | 210913-001 | Aug 14, 2018 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
Sun Pharm | CEQUA | cyclosporine | SOLUTION;OPHTHALMIC | 210913-001 | Aug 14, 2018 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for cequa
See the table below for patents covering cequa around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
China | 109843316 | 含有环孢菌素的局部制剂及其用途 (TOPICAL CYCLOSPORINE-CONTAINING FORMULATIONS AND USES THEREOF) | ⤷ Try a Trial |
Portugal | 2887923 | ⤷ Try a Trial | |
Denmark | 2887923 | ⤷ Try a Trial | |
Lithuania | 2887923 | ⤷ Try a Trial | |
European Patent Office | 2887923 | FORMULATION OPHTALMIQUE D'ACIDE GRAS OU LIPIDIQUE DE POLYOXYLE, ET TRAITEMENT DE PATHOLOGIES OCULAIRES (OPHTHALMIC FORMULATION OF POLYOXYL LIPID OR POLYOXYL FATTY ACID AND TREATMENT OF OCULAR CONDITIONS) | ⤷ Try a Trial |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for cequa
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
2049079 | LUC00006 | Luxembourg | ⤷ Try a Trial | PRODUCT NAME: CYCLOSPORINE (GOUTTES OCULAIRES SOUS FORME D'EMULSION); AUTHORISATION NUMBER AND DATE: EU/1/15/990 20150323 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |